ADL-5747 |
ADL-5747 : Agonist of OPRD1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| OPRD1 |
|
Agonist
up to 10 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Within Target family:
Selective against mu (μ), kappa (κ) receptor
Outside target family:
Evaluate ...
Potency Cellular
In Vitro
OPRD1
Mode of Action: Agonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/jm900773n
In Vivo Validations
Rat
Dose: 2.5 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
5.3 h
Systemic clearance:
3.3 L/h/Kg
Area Under the Curve::
780 ng*h/mL
Volume of Distribution at Steady-State:
18.1 L/Kg
DOI Reference: 10.1021/jm900773n
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
4.9 h
Cmax:
246 ng/mL
Tmax:
1.3 h
Area Under the Curve::
1152 ng*h/mL
Bioavailability:
37.6%
DOI Reference: 10.1021/jm900773n
Dog
Dose: 1.0 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
12.2 h
Systemic clearance:
0.38 L/h/Kg
Area Under the Curve::
2637 ng*h/mL
Volume of Distribution at Steady-State:
5.1 L/Kg
DOI Reference: 10.1021/jm900773n
Dose: 3.0 mg/Kg
Route of delivery:
Oral
Plasma half life:
7.7 h
Cmax:
852 ng/mL
Tmax:
0.4 h
Area Under the Curve::
4203 ng*h/mL
Bioavailability:
54.5%
DOI Reference: 10.1021/jm900773n
Chemical Information
| Molecular Formula | C24H28N2O3 |
| SMILEs | CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)c(O)c1 |
| InChI | InChI=1S/C24H28N2O3/c1-3-26(4-2)23(28)17-9-10-18(21(27)15-17)20-16-24(11-13-25-14-12-24)29-22-8-6-5-7-19(20)22/h5-10,15-16,25,27H,3-4,11-14H2,1-2H3 |
| Molecular weight | 392.21 Da |
| AlogP | 3.8205000000000027 |
| HBond acceptors | 5 |
| HBond donors | 2 |
| Atoms | 57 |